The deletion of atypical chemokine receptor 4 (ACKR4) in colorectal tumor cells but not stromal cells inhibited the migration of DCs to tumor-draining lymph nodes and impaired antigen presentation. Here, ACKR4 is linked to colorectal neoplasm.